Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
Document Type and Number:
WIPO Patent Application WO/2010/075517
Kind Code:
A3
Abstract:
A purified compound having activity against hepatitis C virus is disclosed.

Inventors:
BAO DONGHUI (US)
CHANG WOSNUK (US)
NAGARATHNAM DHANAPALAN (US)
SOFIA MICHAEL JOSEPH (US)
Application Number:
PCT/US2009/069420
Publication Date:
June 21, 2012
Filing Date:
December 23, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PHARMASSET INC (US)
BAO DONGHUI (US)
CHANG WOSNUK (US)
NAGARATHNAM DHANAPALAN (US)
SOFIA MICHAEL JOSEPH (US)
International Classes:
C07H19/04; A61K31/7072; A61K31/7076; A61K31/708; A61P31/18; C07H19/20
Domestic Patent References:
WO2008121634A22008-10-09
WO2005003147A22005-01-13
Other References:
CAHARD D ET AL: "ARYLOXY PHOSPHORAMIDATE TRIESTERS AS PRO-TIDES", MINI REVIEWS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS, HILVERSUM, NL, vol. 4, no. 4, 1 January 2004 (2004-01-01), pages 371 - 381, XP008076430, ISSN: 1389-5575
MURAKAMI EISUKE ET AL: "The mechanism of action of beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcyti dme involves a second metabolic pathway leading to beta-D-2'-deoxy-2-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 52, no. 2, February 2008 (2008-02-01), pages 458 - 464, XP002674431, ISSN: 0066-4804
Attorney, Agent or Firm:
KOWALCHYK, Katherine, M. (P.O. Box 2903Minneapolis, MN, US)
Download PDF: